Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
1
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Sandoz International GmbH
EU Transparency Register
111463951460-07 First registered on 12 Oct 2023
Goals / Remit
Our Purpose at Sandoz is clear: pioneering access for patients. Our Purpose shines through in our rich heritage, as in our plans for the future. Our Vision is to be the world’s leading and most valued generics and biosimilars company. We aim to be valued for how we run our business, but also for the positive impact we have on society. That’s how we will deliver sustainably on our Purpose.
Main EU files targeted
Antimicrobial Resistance, EU Pharmaceutical Legislation, EU Pharmaceutical Strategy, F-Gas Regulation, Industrial Strategy, IP Action Plan, Orphan Medicines Regulation, Pediatric Medicines, Pharmaceutical Pricing, Waste Water Treatment Directive, Critical Medicines Act, Biotech Act
Address
Head Office
Industriestr. 25
Holzkirchen 83607
GERMANYEU Office
Industriestr. 25
Holzkirchen 83607
GERMANYWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 14 Mar 2025
Name Start date End Date Gregor Makuc 06 Nov 2024 01 Jan 2025 Arnaud Maheas 05 Nov 2024 04 Nov 2025 Arnaud MAHÉAS 29 Feb 2024 04 Oct 2024 Complementary Information
In 2024, 1 associate in Brussels spends 50% of working time on activities falling within the scope of the register.
1 associate at Europe headquarters spends up to 25% of working time on activities falling within the scope of the register.
Other associates involved on activities falling within the scope of the register spent less than 10% of their time on such activities.Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Medicines for Europe (including Biosimilar Medicines Sector Group and VAM Sector Group)
European Healthcare Distribution Association (GIRP)
APIC (CEFIC Sector Group)
EPC (European Policy Center)Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount acumen public affairs 10,000€ - 24,999€ fleishman-hillard 10,000€ - 24,999€ Intermediaries for current year
Name acumen public affairs Closed year Costs
100,000€ - 199,999€
Other financial info
We have calculated the estimate of annual costs related to activities that occurred in 2023 after the spin-off from Novartis (October 2023-December 2023) and that are covered by the register by adding our membership fees, event costs, consultancy fees together with facilities (rental charges) and personal costs.
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
None declared
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 07 Jun 2024 Location Kundl, Austria Subject Strategic autonomy and current developments in the medical/pharmaceutical sector Cabinet Cabinet of Commissioner Johannes Hahn Attending - Johannes Hahn (Commissioner)